Demonstration of a chronic myelogenous leukemia clone in acute myelogenous leukemia

被引:0
|
作者
Jeon, Byung Ryul [1 ]
Kim, Se Hyung [2 ]
Park, Sung Kyu [2 ]
Park, Rojin [3 ]
Hong, Dae Sik [2 ]
Lee, You Kyoung [1 ]
机构
[1] Soonchunhyang Univ, Dept Lab Med & Genet, Coll Med, Bucheon, South Korea
[2] Soonchunhyang Univ, Dept Internal Med, Coll Med, Div Hematol & Oncol, Bucheon, South Korea
[3] Soonchunhyang Univ, Dept Lab Med, Coll Med, Seoul, South Korea
来源
BIOMEDICAL RESEARCH-INDIA | 2016年 / 27卷 / 04期
关键词
AML; CML; BCR/ABL1; CD; 34; enrichment; Monosomy; 7; CHRONIC MYELOID-LEUKEMIA; ACUTE MYELOBLASTIC-LEUKEMIA; IMATINIB TREATMENT; PHILADELPHIA-CHROMOSOME; INTERFERON THERAPY; ABNORMALITIES; MONOSOMY-7; HEMATOPOIESIS; EMERGENCE; CELLS;
D O I
暂无
中图分类号
R318 [生物医学工程];
学科分类号
0831 ;
摘要
In the present study, we report a case of a 58-year-old female patient presenting with Philadelphia-chromosome (Ph)-negative blast cells and Ph-positive mature cells at diagnosis. The complete blood cell count showed the patient had a white blood cell count of 35.5 x 10(9)/L and a differential blast count of 62%. A bone marrow biopsy showed closely packed marrow with blast cell infiltration. Blasts were weakly positive for MPO stain, but negative for PAS and ANAE stains. Moreover, blasts tested positive for CD34, CD13, CD117, CD15, CD33, and CD7 and negative for TdT, CD3, CD22, and CD19 in cytometric immunophenotyping experiments. The patient, who had the karyotype 46, XX,t(9; 22) (q34; q11.2) [14]/45, XX, inv(3)(q21q26.2),-7[4], was therefore diagnosed as having AML. Fluorescence in situ hybridization (FISH) showed a decrease in Ph-positive clones and an increase in monosomy 7positive clones after CD34-positive cell enrichment, suggesting that the blasts were primarily Phnegative. This case highlights the necessity of analyzing the cytogenetic characteristics of blasts to better understand the nature of the disease when only a fraction of the cells are Ph-positive.
引用
收藏
页码:1099 / 1101
页数:3
相关论文
共 50 条
  • [1] Chronic Myelomonocytic Leukemia Transforming Into Acute Myelogenous Leukemia
    Clark, Michelle
    LABMEDICINE, 2009, 40 (01): : 19 - 21
  • [3] Chronic myelogenous leukemia
    Mauro, MJ
    Druker, BJ
    CURRENT OPINION IN ONCOLOGY, 2001, 13 (01) : 3 - 7
  • [4] CHRONIC MYELOGENOUS LEUKEMIA
    不详
    JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 1954, 155 (03): : 323 - 323
  • [5] CHRONIC MYELOGENOUS LEUKEMIA
    MOLONEY, WC
    CANCER, 1978, 42 (02) : 865 - 873
  • [6] CHRONIC MYELOGENOUS LEUKEMIA
    GRIGNANI, F
    CRC CRITICAL REVIEWS IN ONCOLOGY/HEMATOLOGY, 1985, 4 (01): : 31 - 66
  • [7] Chronic myelogenous leukemia
    Willis, MS
    Wilson, KS
    LABORATORY MEDICINE, 2002, 33 (03) : 203 - 207
  • [8] Chronic myelogenous leukemia
    O'Dwyer, ME
    CURRENT OPINION IN ONCOLOGY, 2003, 15 (01) : 10 - 15
  • [9] Chronic myelogenous leukemia
    Ernst, Thomas
    Hochhaus, Andreas
    ONKOLOGIE, 2023, 29 (04): : 305 - 314
  • [10] Chronic Myelogenous Leukemia
    O'Brien, Susan
    Berman, Ellin
    Borghaei, Hossein
    DeAngelo, Daniel J.
    Devetten, Marcel P.
    Devine, Steven
    Erba, Harry P.
    Gotlib, Jason
    Jagasia, Madan
    Moore, Joseph O.
    Mughal, Tariq
    Mughal, Tariq
    Radich, Jerald P.
    Radich, Jerald P.
    Shah, Neil P.
    Smith, B. Douglas
    Snyder, David S.
    Snyder, David S.
    Talpaz, Moshe
    Wetzler, Meir
    JOURNAL OF THE NATIONAL COMPREHENSIVE CANCER NETWORK, 2009, 7 (09): : 984 - 1023